Aurobindo Pharma shares rise 6% on import price announcement
after close1 source ↓written by the desknot a recommendation
- after the Directorate
- 6%
- to increase
- 50% to 75%
- was trading
- ₹1,186.75
- ₹1,150.55
Shares of Aurobindo Pharma surged 6% after the Directorate General of Foreign Trade imposed a Minimum Import Price on key antibiotic inputs, including Pen-G and Amoxicillin. This regulatory change is expected to enhance the company's pricing power and competitiveness, with capacity utilization projected to increase from 50% to 75%.
The stock was trading at ₹1,186.75, up from ₹1,150.55, reflecting strong market sentiment following the announcement.
Not investment advice. For informational purposes only.